RAMIREZ, GIUSEPPE ALVISE
 Distribuzione geografica
Continente #
AS - Asia 2.146
NA - Nord America 1.793
EU - Europa 1.485
SA - Sud America 395
AF - Africa 61
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.912
Nazione #
US - Stati Uniti d'America 1.691
SG - Singapore 802
CN - Cina 713
IT - Italia 619
BR - Brasile 341
HK - Hong Kong 249
SE - Svezia 231
DE - Germania 162
VN - Vietnam 128
GB - Regno Unito 106
RU - Federazione Russa 89
FI - Finlandia 63
CA - Canada 62
IN - India 57
NL - Olanda 39
MX - Messico 32
AU - Australia 31
JP - Giappone 31
PL - Polonia 31
TR - Turchia 31
AT - Austria 30
ZA - Sudafrica 27
AR - Argentina 22
ES - Italia 22
BD - Bangladesh 21
FR - Francia 20
ID - Indonesia 17
IR - Iran 17
IE - Irlanda 16
BE - Belgio 14
EG - Egitto 14
IQ - Iraq 14
LT - Lituania 14
PK - Pakistan 13
EC - Ecuador 9
UA - Ucraina 9
TN - Tunisia 8
CO - Colombia 7
IL - Israele 7
PY - Paraguay 7
SA - Arabia Saudita 7
MA - Marocco 5
PH - Filippine 5
CL - Cile 4
CY - Cipro 4
KE - Kenya 4
MY - Malesia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JO - Giordania 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
HR - Croazia 2
LB - Libano 2
PE - Perù 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LI - Liechtenstein 1
ME - Montenegro 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
SC - Seychelles 1
TL - Timor Orientale 1
VE - Venezuela 1
Totale 5.912
Città #
Singapore 438
Dallas 294
Ashburn 248
Hong Kong 239
Milan 169
Shanghai 167
Beijing 152
New York 124
Hefei 106
Boardman 80
Los Angeles 76
Munich 68
Ho Chi Minh City 50
Rome 48
Lawrence 42
Princeton 42
Santa Clara 38
Nuremberg 36
Helsinki 34
Moscow 34
Denver 30
São Paulo 30
Tokyo 30
Hanoi 29
Warsaw 27
Brooklyn 24
London 24
Montreal 23
Chicago 22
Guangzhou 21
Atlanta 20
Poplar 20
Rio de Janeiro 20
Ankara 19
Bari 18
Turku 17
Falkenstein 16
Genoa 16
Houston 15
Seattle 15
Chennai 14
Toronto 14
Washington 14
Boston 13
Mexico City 13
Orem 13
Stockholm 13
Vienna 13
Dublin 12
Johannesburg 12
Manchester 12
Belo Horizonte 11
Brussels 11
Cesano Boscone 11
Cape Town 10
Lappeenranta 10
Pune 10
Wollongong 10
Changsha 9
Phoenix 9
Shenzhen 9
Amsterdam 8
Brisbane 8
Central 8
Mumbai 8
Secaucus 8
The Dalles 8
Bologna 7
Cairo 7
Melbourne 7
Mugnano di Napoli 7
Querétaro 7
San Francisco 7
Cincinnati 6
Council Bluffs 6
Frankfurt am Main 6
Hangzhou 6
Hải Dương 6
St Petersburg 6
Topeka 6
Turin 6
Baghdad 5
Buffalo 5
Cagliari 5
Campinas 5
Curitiba 5
Dhaka 5
Haiphong 5
Istanbul 5
Jakarta 5
Joinville 5
Ottawa 5
Pisa 5
Stanford 5
Sydney 5
Vittoria 5
Arezzo 4
Asunción 4
Augusta 4
Bengaluru 4
Totale 3.393
Nome #
Multidirectional dysfunction of the immune response in patients with systemic lupus erythematosus 291
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 178
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 135
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 131
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 106
A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-centre cohort 96
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 94
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 92
Biobanking for COVID-19 research 84
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 84
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 80
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 79
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 78
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 78
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 77
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 75
LENGTH OF STAY IN INTERNAL MEDICINE: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 73
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 72
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 70
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 70
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 70
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 69
Chromogranin A plasma levels predict mortality in COVID-19 69
Testosterone in males with COVID-19: A twelve-month cohort study 69
PTX3 intercepts vascular inflammation in systemic immune-mediated diseases 69
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 68
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature 65
A continuity care program in chronic, complex and frail patients: the PRO-CCF study protocol 65
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19 65
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 65
HOSPITALIZATION COURSE AND OUTCOMES OF CANCER PATIENTS ADMITTED TO INTERNAL MEDICINE UNITS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 65
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 64
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 63
Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study 63
Severely low testosterone in males with COVID-19: a case-control study 62
Influence of reduced muscle mass and quality on ventilator weaning and complications during intensive care unit stay in COVID-19 patients 62
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 62
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases 61
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 61
COVID-19: Pharmacology and kinetics of viral clearance 61
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 60
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) PRESENTING WITH THYROID DYSFUNCTION: A CASE REPORT 60
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 58
Urgent manifestations of immunoglobulin G4-related disease 58
Platelet prothrombotic activity in COVID-19 survivors with persisting respiratory symptoms after 2 years from hospital discharge 55
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 55
Six-month respiratory outcomes and exercise capacity of COVID-19 acute respiratory failure patients treated with continuous positive airway pressure 55
INTRODUCING A NOVEL HOSPITAL-TO-HOME CARE PROGRAMME IN CHRONIC/COMPLEX/FRAIL PATIENTS: THE PRO-CCF STUDY 55
Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors 53
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 53
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 53
INTRODUCING SUSTAINABILITY IN MEDICINE:THE SIM STUDY 53
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 52
Sustainability in Internal Medicine: A Year-Long Ward-Wide Observational Study 50
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 50
MACROPHAGE ACTIVATION SYNDROME IN EARLY SYSTEMIC LUPUS ERYTHEMATOSUS: A CLINICAL CASE REPORT 50
Neutrophil Extracellular Traps in the Autoimmunity Context 50
DIFFERENTIAL PROFILES OF BACTEREMIA IN EMERGENCY AND MEDICINE DEPARTMENTS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 50
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 49
Choroidal Neovascularization in a Patient with Crohn's Disease 49
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 49
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 48
A CASE OF PRIMARY ADRENAL EBV+ EXTRANODAL NK/T-CELL LYMPHOMA 47
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 47
EFFICACY AND SAFETY OF CONTINUOUS POSITIVE AIRWAY PRESSURE AND PATIENT MOBILIZATION FOR ARDS DUE TO COVID-19 IN A NON-ICU SETTING 47
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 45
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 45
Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis 45
NONBACTERIAL THROMBOTIC ENDOCARDITIS AND DIFFUSED INTRAVASCULAR COAGULATION IN RAPIDLY PROGRESSING PROSTATIC ADENOCARCINOMA: A CLINICAL CASE 45
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 44
Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice 44
Quantitative MRI adds to neuropsychiatric lupus diagnostics 44
PYODERMA GANGRENOSUM REVEALING TAKAYASU ARTERITIS IN A 65-YEAR-OLD CAUCASIAN WOMAN: A CASE REPORT 43
Infection-Associated Flares in Systemic Lupus Erythematosus 43
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): Prospective study 42
Testosterone in males with COVID-19: A 7-month cohort study 42
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 42
WHIPPLE’S BACKLASH: IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. A CASE REPORT 41
BEHEADED MENINGITIS: A CASE REPORT 40
Choroid plexus and perivascular spaces enlargement in neuropsychiatric systemic lupus erythematosus 39
DISCORDANT DIAGNOSIS OF PULMONARY LYMPHOMATOID GRANULOMATOSIS AND EBVNEGATIVE DIFFUSE LARGE B-CELL LYMPHOMA IN THE SAME PATIENT, A CASE REPORT 39
Colchicine treatment in community healthcare setting to prevent severe COVID-19. 39
Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine 39
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 38
SECOND AND THIRD LINE ANTIMICROBIAL THERAPY IN INTERNAL MEDICINE DEPARTMENTS: A PROSPECTIVE ANALYSIS ON PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 38
Selective serotonin reuptake inhibitors and fractures in older nursing home residents: Data from the INCUR study 38
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 38
PLASMA AND TISSUE EXPRESSION OF PTX3 IN PATIENTS WITH CHRONIC PERIAORTITIS 38
COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients 37
Misunderstandings between platelets and neutrophils build in chronic inflammation 36
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): Cross-sectional analysis 36
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTRE REAL-LIFE EXPERIENCE 35
Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis 35
Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation 34
Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives 34
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 32
LUPUS LOW-DISEASE ACTIVITY STATE VS SLE RESPONDER INDEX IN A "REAL-LIFE" SETTING 31
Evidence for charge-based mimicry in anti dsDNA antibody generation 30
Serum IgG4 level predicts COVID-19 related mortality 27
Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms 27
Totale 5.992
Categoria #
all - tutte 36.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 13 3 1 2 0 3 1
2021/2022163 3 0 2 22 4 22 9 12 15 9 30 35
2022/2023510 112 93 48 18 25 55 46 53 13 10 19 18
2023/2024708 26 42 72 61 54 142 41 67 15 28 57 103
2024/20251.967 129 67 97 98 151 177 231 211 208 174 153 271
2025/20262.755 517 420 379 805 581 53 0 0 0 0 0 0
Totale 6.134